By IFA analysis, we observed that for untreated NSCLC cells, anti-PKM2 antibody immunostaining identified ≥2+ staining of cytoplasmic PKM2 and ≤ 1+ staining of nuclei (Fig 4B). The gene discussed is PKM; the disease is non-small cell lung carcinoma.